PDRX
Price
$3.20
Change
+$0.15 (+4.92%)
Updated
Dec 18 closing price
SHPMY
Price
$8.00
Change
-$0.75 (-8.57%)
Updated
Dec 18 closing price
Ad is loading...

PDRX vs SHPMY

Header iconPDRX vs SHPMY Comparison
Open Charts PDRX vs SHPMYBanner chart's image
PD-RX Pharmaceuticals
Price$3.20
Change+$0.15 (+4.92%)
Volume$1K
CapitalizationN/A
Shanghai Pharmaceuticals Holdings
Price$8.00
Change-$0.75 (-8.57%)
Volume$1.64K
CapitalizationN/A
PDRX vs SHPMY Comparison Chart
Loading...
PDRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PDRX vs. SHPMY commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PDRX is a Hold and SHPMY is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (PDRX: $3.20 vs. SHPMY: $8.00)
Brand notoriety: PDRX and SHPMY are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: PDRX: 41% vs. SHPMY: 67%
Market capitalization -- PDRX: $0 vs. SHPMY: $9.5B
PDRX [@Medical Distributors] is valued at $0. SHPMY’s [@Medical Distributors] market capitalization is $9.5B. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $9.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PDRX’s FA Score shows that 0 FA rating(s) are green whileSHPMY’s FA Score has 0 green FA rating(s).

  • PDRX’s FA Score: 0 green, 5 red.
  • SHPMY’s FA Score: 0 green, 5 red.
According to our system of comparison, SHPMY is a better buy in the long-term than PDRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PDRX’s TA Score shows that 3 TA indicator(s) are bullish while SHPMY’s TA Score has 4 bullish TA indicator(s).

  • PDRX’s TA Score: 3 bullish, 3 bearish.
  • SHPMY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both PDRX and SHPMY are a good buy in the short-term.

Price Growth

PDRX (@Medical Distributors) experienced а +4.92% price change this week, while SHPMY (@Medical Distributors) price change was -0.12% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +0.86%. For the same industry, the average monthly price growth was +2.51%, and the average quarterly price growth was +147.05%.

Industries' Descriptions

@Medical Distributors (+0.86% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SHPMY YTD gains are higher at: 16.659 vs. PDRX (-54.286).
PDRXSHPMYPDRX / SHPMY
CapitalizationN/A9.5B-
EBITDAN/A11.1B-
Gain YTD-54.28616.659-326%
P/E RatioN/A8.39-
RevenueN/A241B-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
PDRX vs SHPMY: Fundamental Ratings
PDRX
SHPMY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
39
Fair valued
PROFIT vs RISK RATING
1..100
10079
SMR RATING
1..100
10081
PRICE GROWTH RATING
1..100
8643
P/E GROWTH RATING
1..100
10036
SEASONALITY SCORE
1..100
n/a95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SHPMY's Valuation (39) in the null industry is in the same range as PDRX (44). This means that SHPMY’s stock grew similarly to PDRX’s over the last 12 months.

SHPMY's Profit vs Risk Rating (79) in the null industry is in the same range as PDRX (100). This means that SHPMY’s stock grew similarly to PDRX’s over the last 12 months.

SHPMY's SMR Rating (81) in the null industry is in the same range as PDRX (100). This means that SHPMY’s stock grew similarly to PDRX’s over the last 12 months.

SHPMY's Price Growth Rating (43) in the null industry is somewhat better than the same rating for PDRX (86). This means that SHPMY’s stock grew somewhat faster than PDRX’s over the last 12 months.

SHPMY's P/E Growth Rating (36) in the null industry is somewhat better than the same rating for PDRX (100). This means that SHPMY’s stock grew somewhat faster than PDRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PDRXSHPMY
RSI
ODDS (%)
Bullish Trend 4 days ago
33%
N/A
Stochastic
ODDS (%)
Bullish Trend 5 days ago
43%
Bullish Trend 4 days ago
73%
Momentum
ODDS (%)
Bearish Trend 4 days ago
41%
Bullish Trend 4 days ago
54%
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
62%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
29%
Bearish Trend 4 days ago
63%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
31%
Bearish Trend 4 days ago
67%
Advances
ODDS (%)
N/A
Bullish Trend 7 days ago
59%
Declines
ODDS (%)
N/A
Bearish Trend 18 days ago
60%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
35%
Bearish Trend 4 days ago
66%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
63%
View a ticker or compare two or three
Ad is loading...
PDRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSFFX18.950.16
+0.85%
MFS Total Return R1
GGGCX48.340.29
+0.60%
Gabelli Global Growth C
FWDDX10.640.04
+0.39%
American Funds Dvlpg Wld Gr&Inc 529-F-2
AGGDX11.290.04
+0.36%
American Century Focused Global Gr R6
MSJAX16.570.03
+0.18%
Morgan Stanley Global Endurance A

PDRX and

Correlation & Price change

A.I.dvisor tells us that PDRX and NSVGF have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PDRX and NSVGF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PDRX
1D Price
Change %
PDRX100%
N/A
NSVGF - PDRX
8%
Poorly correlated
N/A
MAHLY - PDRX
2%
Poorly correlated
N/A
SHPMY - PDRX
0%
Poorly correlated
N/A
ARRJF - PDRX
0%
Poorly correlated
N/A
MEPDF - PDRX
0%
Poorly correlated
N/A
More

SHPMY and

Correlation & Price change

A.I.dvisor tells us that SHPMY and NSVGF have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SHPMY and NSVGF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHPMY
1D Price
Change %
SHPMY100%
N/A
NSVGF - SHPMY
14%
Poorly correlated
N/A
COSM - SHPMY
12%
Poorly correlated
-5.82%
SHTDF - SHPMY
12%
Poorly correlated
-2.35%
ZYXI - SHPMY
7%
Poorly correlated
-1.79%
SHPMF - SHPMY
7%
Poorly correlated
N/A
More